4.5 Article

Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases

Journal

CURRENT OPINION IN NEUROBIOLOGY
Volume 48, Issue -, Pages 52-58

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.conb.2017.09.005

Keywords

-

Categories

Funding

  1. NIH [R01AG051390, U54NS100717, K99 AG053439]
  2. Consortium for Frontomtemporal dementia
  3. Rainwater Foundation
  4. Bluefield fellowship
  5. CART Organization
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS100717] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON AGING [R01AG051390, K99AG053439] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Endo-lysosomal pathways are essential in maintaining protein homeostasis in the cell. Numerous genes in the endo-lysosomal pathways have been found to associate with neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and frontotemporal dementia (FTD). Mutations of these genes lead to dysfunction in multiple steps of the endo-lysosomal network: autophagy, endocytic trafficking and lysosomal degradation, resulting in accumulation of pathogenic proteins. Although the exact pathogenic mechanism varies for different disease-associated genes, dysfunction of the endo-lysosomal pathways represents a converging mechanism shared by these diseases. Therefore, strategies that correct or compensate for endolysosomal dysfunction may be promising therapeutic approaches to treat neurodegenerative diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available